We also had to limit the functional analyses to the total CD14+ monocyte population rather than co-culturing enriched CD14+ subtypes with CLL cells in refined analyses including different CX3CR1 expression levels [48]. The gene discussed is CX3CR1; the disease is B-cell chronic lymphocytic leukemia.